Skip to content

Effect of Eucommia Yaotong Pill on Bone Mineral Density, Bone Metabolism Index and Hormone Level in Elderly Patients with Osteoporotic Low Back Pain Based on the Theory of Synergistic Treatment of Different Diseases

Effect of Eucommia Yaotong Pill on Bone Mineral Density, Bone Metabolism Index and Hormone Level in Elderly Patients with Osteoporotic Low Back Pain Based on the Theory of Synergistic Treatment of Different Diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024376
Enrollment
Unknown
Registered
2019-07-08
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Senile osteoporosis

Interventions

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Compliance with WHO criteria for osteoporosis or severe osteoporosis; 2. Accord with the syndrome manifestation of kidney deficiency and blood stasis; 3. Men over 70 years old and women over 65 years old. 4. According to the relevant medical history, age and biochemical indexes of bone metabolism, low-conversion osteoporosis was identified. 5. Volunteer to join the clinical experimental researcher.

Exclusion criteria

Exclusion criteria: 1. Secondary osteoporosis: endocrine and metabolic diseases such as type 1 diabetes mellitus, hypogonadism, hyperthyroidism, parathyroidism, Gushing syndrome, etc. or systemic diseases such as intestinal malabsorption syndrome, anorexia nervosa, muscular dystrophy, systemic lupus erythematosus, chronic renal failure, rheumatic arthritis, myelofibrosis, leukemia, malnutrition, etc.. 2. Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; 3. Those with fresh fracture who need to stay in bed for a long time; 4. Failure to use drugs as prescribed, failure to determine the efficacy or incomplete data, and other cases that affect the judgment of efficacy.

Design outcomes

Primary

MeasureTime frame
Bone metabolic markers;

Countries

China

Contacts

Public ContactHuanping Zhu

Gansu Provincial Hospital of Traditional Chinese Medicine

1340025823@qq.com+86 13909487649

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026